LEXICON PHARMACEUTICALS INC - NOTE 5.250%12/0

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Debt / NOTE 5.250%12/0
Market price (% of par)
40.75%
Total 13F principal
$32,839,000
Principal change
$0
Total reported market value
$14,774,121
Number of holders
8

Institutional Holders of LEXICON PHARMACEUTICALS INC - NOTE 5.250%12/0 as of Q2 2020

As of 30 Jun 2020, LEXICON PHARMACEUTICALS INC - NOTE 5.250%12/0 was held by 8 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $32,839,000 in principal (par value) of the bond. The largest 8 bondholders included LAZARD ASSET MANAGEMENT LLC, WOLVERINE ASSET MANAGEMENT LLC, DEUTSCHE BANK AG\, BNP PARIBAS ARBITRAGE, SA, Verition Fund Management LLC, JPMORGAN CHASE & CO, MACKAY SHIELDS LLC, and Federation des caisses Desjardins du Quebec. This page lists 8 institutional bondholders reporting positions for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.